Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris

Michelle K.Y. Chen, Ravi Vissapragada, Norma Bulamu, Monisha Gupta, Victoria Werth, Deshan Frank Sebaratnam

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences